Effect ofaddition of trimetazidine on LV function in patients with LV systolic dysfunction receiving optimal medical therapy in comparison with patients receiving only optimal medical therapy in a tertiary care centre

Journal Title: Medpulse International Journal of Pharmacology - Year 2019, Vol 10, Issue 3

Abstract

Background: Left ventricular dysfunction (LVD) can lead to congestive cardiac failure.LVD was traditionally managed by antiplatelets, diuretics, antihypertensives and statins. However studies have shown that addition of Trimetazidine(TMZ) to standard treatment improve LV function and thus symptomatic improvement in patients. Many studies from western countries have shown beneficial effect of Trimetazidine in terms of LV function improvement.However not much data is available regarding the effect of Trimetazidine on LV function in Indian population. Hence this study was plannedin Indian population.Objectives: To find the effect ofaddition of Trimetazidine onLeft ventricular function, in patients with LV systolic dysfunction receiving optimal medical therapyin comparison with patients receiving only optimal medical therapyMaterialsand Methods: Studywas conducted in Department of Cardiology,KannurMedical College,Anjarakandy. Approval fromInstitutional HumanEthical Committee and Research Committeewas obtained.Thisis acomparativestudy in patients with LV systolic dysfunction receivingTrimetazidinealongwith optimal medical therapyand patients receiving only optimalmedical therapy.Study period was from November 2014 to August 2015.Results: In TMZ group, left ventricular systolic function improved significantly compared to optimal medical therapy group. In TMZ group LEVF showed an improvement of 42.56±6.59 vs 35.63±4.70 with a p value of <0.001.Conclusion: TMZ, a specific partial inhibitor of FFA oxidation, added to optimal medical therapy improved left ventricular function.Although highly suggestive, evaluation of effects of partial free fatty acid oxidation inhibition in patients with LVD requires further investigation through large scale, multicentre, randomised placebo controlled trials.Whether the observed beneficial effect of metabolic modulation in LVD, results in decreased morbidity and mortality, needs further evaluation as well.

Authors and Affiliations

Shabnam Narayanan, P N Krishna Kumar

Keywords

Related Articles

Experimentally induced gastric ulceration on guinea pigs and study of protection afford by ambrex (a poly herbal drugs) and sucralfate

Problem Statement Gastric ulcer is a very common disease now a days and with a increasing incidence. It is more common in males than females and prevalent between people 50-65 years. In the present study acute gastric ul...

Patterns of prescription in a psychiatry out-patient department in a tertiary teaching hospital

Background: There is constantly increasing prevalence of psychiatric morbidity in Jammu and Kashmir State. Study of prescription pattern helps us to monitor, evaluate and if necessary suggest modifications in prescribing...

Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study

Background:Metformin and Vildagliptin have independent glucose-lowering properties and may increase GLP-1 levels by working through complementary mechanisms. The combination of metformin and glimepiride is a well-establi...

Comparative effect of glimepride and metformin as a monotherapy on oxidative stress in T2DM patients

Aims and Objective: To compare antioxidant effect of glimepride and metformin alone in T2DM patients Material and Methods: T2DM patients having duration of less than 5 years were randomly selected and grouped in to two g...

Effect of ciprofloxacin: A fluoroquinolone drug on psychomotor performance tests and blood sugar level in healthy humans

Background: Fluoroquinolones are widely used for infections butcan affect psychomotor function. Ciprofloxacin is known to cause anxiety, impairment of concentration, abnormal vision. Previous studies indicated a relation...

Download PDF file
  • EP ID EP615754
  • DOI 10.26611/10101031
  • Views 80
  • Downloads 0

How To Cite

Shabnam Narayanan, P N Krishna Kumar (2019). Effect ofaddition of trimetazidine on LV function in patients with LV systolic dysfunction receiving optimal medical therapy in comparison with patients receiving only optimal medical therapy in a tertiary care centre. Medpulse International Journal of Pharmacology, 10(3), 23-27. https://europub.co.uk./articles/-A-615754